Expression and clinical significance of runt-related transcription factor 3 in children with bronchiolitis.
- Author:
Shuai MEN
1
;
Yan-Yan YU
;
Yu-Hong ZHANG
;
Yi-Fen WANG
;
Qian QIAN
;
Wei LI
;
Chuang YIN
Author Information
1. Department of Pediatric Asthma, Lianyungang Maternal and Child Health Care Hospital, Lianyungang, Jiangsu 222006, China. wangjunhuayyy@sina.com.
- Publication Type:Journal Article
- MeSH:
Asthma;
Bronchiolitis;
Child;
Child, Preschool;
Core Binding Factor Alpha 3 Subunit;
genetics;
Humans;
Interferon-gamma;
Leukocytes, Mononuclear
- From:
Chinese Journal of Contemporary Pediatrics
2019;21(10):1005-1011
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To study the mRNA level of runt-related transcription factor 3 (RUNX3) in children with bronchiolitis and its clinical significance in bronchiolitis.
METHODS:A total of 54 young children with bronchiolitis were enrolled as the bronchiolitis group, among whom 28 with atopic constitution were enrolled in the atopic bronchiolitis group and 26 with non-atopic constitution were enrolled in the non-atopic bronchiolitis group. A total of 48 healthy young children were enrolled as the healthy control group, among whom 24 with atopic constitution were enrolled in the atopic healthy control group and 24 with non-atopic constitution were enrolled in the non-atopic healthy control group. Quantitative real-time PCR was used to measure the mRNA level of RUNX3 in peripheral blood mononuclear cells. ELISA was used to measure the serum levels of interleukin-4 (IL-4) and interferon gamma (IFN-γ).
RESULTS:The bronchiolitis group had a significantly lower mRNA level of RUNX3 than the healthy control group, and the atopic bronchiolitis group had a significantly lower mRNA level of RUNX3 than the non-atopic bronchiolitis, atopic healthy control, and non-atopic healthy control groups (P<0.05). The bronchiolitis group had a significantly higher serum level of IL-4 than the healthy control group, and the atopic bronchiolitis group had a significantly higher serum level of IL-4 than the non-atopic healthy control group (P<0.05). The bronchiolitis group had a significantly lower serum level of IFN-γ than the healthy control group, and the atopic bronchiolitis group had a significantly lower serum level of IFN-γ than the non-atopic bronchiolitis, atopic healthy control, and non-atopic healthy control groups (P<0.05). The correlation analysis showed that the mRNA level of RUNX3 was negatively correlated with the serum level of IL-4 and was positively correlated with the serum level of IFN-γ (P<0.05).
CONCLUSIONS:Measurement of RUNX3 gene expression in peripheral blood mononuclear cells has a certain value in identifying children with atopic constitution at high risk of asthma among children with bronchiolitis.
